From Our Perspective

We Question Rep. Buddy Carter’s Affection for 340B

For years, U.S. Rep. Buddy Carter (R-Ga.) has been a strident critic of the 340B Drug Discount Program. He has reliably echoed Big Pharma’s talking points, calling it "plagued by ...

What Big Pharma Gets Wrong About 340B

For years, the prescription drug industry has had a stranglehold on the American wallet. We’ve all seen the headlines: skyrocketing insulin prices, life-saving cancer drugs that cost more than a ...

The Populist Mask Falls Off Kennedy's Face

When Robert F. Kennedy Jr. was nominated to lead the Department of Health and Human Services (HHS), he promised a "MAHA" revolution—to Make America Healthy Again in part by taking ...

Don’t Sell Out Rural Health Care Providers to Big Pharma

President Trump has launched the TrumpRx website with much fanfare, demonstrating a commitment to lowering medicine prices for Americans. But simultaneously, his administration is helping powerful pharmaceutical companies undermine the ...

Lilly Moves to Undermine 340B Again

Eli Lilly and Company has made good sport of undermining the 340B Drug Discount Program and is once again bullying safety-net hospitals – this time with unworkable and burdensome administrative ...

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields